top of page
logo
Retatrutide Peptide

Retatrutide Peptide

$199.00 Regular Price
$135.00Sale Price

Retatrutide is an experimental, once-weekly injectable peptide developed by Eli Lilly. As a "triple agonist," it acts on three metabolic receptors: GLP-1, GIP, and glucagon. Clinical trials suggest it could be one of the most effective weight-loss and diabetes treatments ever studied.

Here is a breakdown of how it works, its clinical results, and safety considerations:

How It Works

Unlike traditional drugs (like Ozempic) that target a single receptor, retatrutide stimulates three pathways in the body:

  • GLP-1 and GIP: Suppress appetite, increase satiety, and regulate insulin secretion.

  • Glucagon (GCG): Increases energy expenditure (how many calories you burn) and helps break down fat cells.

Clinical Trial Results

Studies indicate unprecedented efficacy for weight loss and blood sugar control:

  • Weight Loss: In Phase 2 trials, participants taking the highest doses lost an average of 24% to 24.4% of their body weight at 48 weeks.

  • Phase 3 Trials: Ongoing late-stage Phase 3 trials are expected to finalize by early to mid-2026, which may lead to commercial FDA/Health Canada approvals in 2027.

Safety Profile & Side Effects

The adverse effects of retatrutide are largely similar to existing incretin mimetics:

  • Common side effects: Nausea, vomiting, and constipation.

  • Other symptoms: Some participants reported a reduced appetite and unusual skin sensations.

Warnings & Availability

Because retatrutide is still in the trial phase, it is not currently FDA-approved for commercial sale and cannot be prescribed by doctors.

  • Health Canada Warnings: Regulatory bodies—including Health Canada—have explicitly warned against buying unapproved, injectable peptide drugs online for weight loss or bodybuilding.

  • Risks: Illegally compounded or counterfeit versions of retatrutide carry severe risks, including inconsistent dosing, contamination, and unknown side effects.

Disclaimer: Since retatrutide is still an investigational medication, you should consult a licensed healthcare provider for advice on managing weight or metabolic health.

    bottom of page